A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

BACKGROUND: Clarithromycin-based therapy is important for Helicobacter pylori eradication treatment. However, clarithromycin may increase cardiovascular risk. Hence, we investigated the association between clarithromycin use and outcomes in adults with stable coronary heart disease (CHD) and subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Chun, Li, Yi-Da, Yu, Ben-Hui, Chen, Yi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469559/
https://www.ncbi.nlm.nih.gov/pubmed/36096732
http://dx.doi.org/10.1186/s12876-022-02498-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469559/
https://www.ncbi.nlm.nih.gov/pubmed/36096732
http://dx.doi.org/10.1186/s12876-022-02498-1

Ejemplares similares